ArticlePharmacoEconomics - open2022

The Societal Economic Impact of Secukinumab in First-Line Treatment of Moderate to Severe Plaque Psoriasis in Germany: An Open-Cohort Simulation.

Ahmed H Seddik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.